Adv Photonix -A (API): CFO Jeffrey J Anderson Bought 20,224 Shares
CFO of Adv Photonix -A (API) Jeffrey J Anderson bought 20,224 shares on 02/28/2012 at an average price of $0.75. Advanced Photonix, Inc. is engaged in the development and manufacture of optoelectronic semiconductor based components, hybrid assemblies and other proprietary solid state light and radiation detection devices, including proprietary advanced solid state silicon photodetection devices which utilize Avalanche Photodiode technology. Adv Photonix -a has a market cap of $25.4 million; its shares were traded at around $0.7282 with a P/E ratio of 81.8 and P/S ratio of 0.9.
Advanced Photonix, Inc. reported its third quarter fiscal 2012 results ending December 30, 2011. The Company's revenues for the quarter ended December 30, 2011 were $6.5 million, a decrease of 16% (or $1.2 million) over revenues of $7.7 million for the quarter ended December 31, 2010. Quarterly net loss was $812,000 or $0.03 per diluted share, as compared to a net loss of $649,000, or $0.03 per diluted share, for the quarter ended December 31, 2010. Net Sales for the nine months were $23 million, an increase of $2 million or 10% compared to the nine months ended December 31, 2010.
CFO Jeffrey J Anderson, Director Lance Brewer, and Director Lance Brewer bought shares of API stock.
Valeant Pharmaceuticals International, Inc. (NYSE:VRX): EVP and CFO Howard Bradley Schiller Bought 27,800 Shares
EVP and CFO of Valeant Pharmaceuticals International, Inc. (NYSE:VRX) Howard Bradley Schiller bought 27,800 shares during the past week at an average price of $53.64. Valeant Pharmaceuticals International, Inc. is a pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. Valeant Pharma has a market cap of $16.58 billion; its shares were traded at around $55.58 with a P/E ratio of 20 and P/S ratio of 6.7.
Valeant Pharmaceuticals International, Inc. announces fourth quarter financial results for 2011. Total reported revenue was $688.4 million in the fourth quarter of 2011 as compared to $514.6 million in the fourth quarter of 2010 primarily attributable to acquisitions completed in 2011 and the growth of key dermatology brands, partly offset by a negative foreign exchange impact.
CFO Howard Bradley Schiller, EVP Administration & CHCO Brian M. Stolz, and Global Head of R&D Susan Hall sold 16,120 shares of VRX stock on 03/07/2012 at the average price of 54.5. The price of the stock has increased by 1.98% since.
Corelogic Inc (NYSE:CLGX): CFO Frank Martell Bought 15,000 Shares
CFO of Corelogic Inc (NYSE:CLGX) Frank Martell bought 15,000 shares on 03/01/2012 at an average price of $15.4. CoreLogic, Inc., formerly known as First American Corp. Corelogic Inc has a market cap of $1.65 billion; its shares were traded at around $15.96 with a P/E ratio of 18.7 and P/S ratio of 1.2.
CoreLogic reported financial results for the fourth quarter and full-year ended December 31, 2011. Fourth quarter revenues went up 9.5% benefiting from strong data, analytics and mortgage services volumes. Full year 2011 revenues went up 4.6% despite challenging market conditions. Fourth quarter income from continuing operations totaled $15.4 million, a $17.8 million decrease from the same prior year period
CFO Frank Martell bought shares of CLGX stock.
Agilysys Inc (NASDAQ:AGYS): SVP, CFO & Treasurer Robert R Ellis Bought 10,000 Shares
SVP, CFO & Treasurer of Agilysys Inc (NASDAQ:AGYS) Robert R Ellis bought 10,000 shares on 03/06/2012 at an average price of $8. Agilysys, Inc. is a provider of innovative IT solutions to corporate and public-sector customers, with special expertise in select vertical markets, including retail and hospitality. Agilysys Inc has a market cap of $176.4 million; its shares were traded at around $8.23 with and P/S ratio of 0.3.
Agilysys, Inc. announced unaudited financial results for the fiscal 2012 third quarter and nine months ended December 31, 2011. Total net sales declined 12.6% to $51.6 million, compared with $59.0 million in the same prior-year period The net loss from continuing operations for the quarter was $5.8 million, or $0.26 per share, compared with a loss from continuing operations of $2.3 million, or $0.10 per share, last year.
President & CEO Jim Dennedy, SVP, CFO & Treasurer Robert R Ellis, and SVP, GC and Secretary Kyle C Badger bought shares of AGYS stock.
Om Group Inc (NYSE:OMG): VP and CFO Christopher M Hix Bought 5,000 Shares
VP and CFO of Om Group Inc (NYSE:OMG) Christopher M Hix bought 5,000 shares on 03/02/2012 at an average price of $25.33. OM Group, Inc. is a international producer and marketer ofvalue-added metal-based specialty chemicals and powders. Om Group Inc has a market cap of $819.8 million; its shares were traded at around $24.9 with a P/E ratio of 6.7 and P/S ratio of 0.5. Om Group Inc had an annual average earnings growth of 1% over the past 5 years.
OM Group, Inc. announced financial results for the fourth quarter and full year ended December 31, 2011. Full year consolidated net sales increased 27 percent in 2011 to $1,514.5 million. Net income was $37.9 million.
Chairman and CEO Joseph Scaminace and VP and CFO Christopher M Hix bought shares of OMG stock.
or the complete list of stocks that bought by their CFOs, go to: Insider Buys.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys:: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.